Powder: -20°C for 3 years
In solvent: -80°C for 2 years
TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(<a href="/target/BTK" style="display: inline; color: #c13a36">BTK</a>). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 92.00 | |
5 mg | In stock | $ 131.00 | |
10 mg | In stock | $ 212.00 | |
25 mg | In stock | $ 397.00 | |
50 mg | In stock | $ 677.00 | |
100 mg | In stock | $ 1,127.00 | |
200 mg | In stock | $ 1,687.00 | |
500 mg | In stock | $ 2,537.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 153.00 |
Description | TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(BTK). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM. |
Targets&IC50 | BTK:1.5 nM, BTK:11.9 nM(Ki) |
Molecular Weight | 447.514 |
Formula | C25H26FN5O2 |
CAS No. | 1415823-49-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 250 mg/mL (558.66 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TL-895 1415823-49-2 Angiogenesis Tyrosine Kinase/Adaptors BTK anti-viral Inhibitor Bruton tyrosine kinase TL895 Myelofibrosis Solid Tumor Carcinoma Acute Myeloid Leukemia Btk Cancer TL 895 Sars-CoV2 COVID-19 inhibit inhibitor